Trans people routinely receive medical transition care with no structured support before it begins and none after it ends. This is a healthcare design failure, not an individual one. The absence of pre-care and post-care leaves trans people navigating the most significant physiological and psychological changes of their lives entirely alone, at precisely the moments when structured guidance matters most.
Someone asked a question that exposes a system
It started, as so many of the clearest clinical questions do, with one person. They wanted to know what support was available before they began hormones, and what would happen once treatment was underway. The honest answer was: almost nothing, and almost nothing. What looks like an individual question is actually a description of how the whole system is designed, or rather how it is not.
Trans healthcare, where it exists at all, is built around the intervention. The hormone prescription. The referral for surgery. The letter of support. The system orients itself entirely toward that moment, and the moment it arrives, the system's attention moves elsewhere. What happens in the weeks and months before that moment, and in the years that follow it, is largely left to the individual to manage alone.
That is not a gap. It is a design failure. And it is time to name it as one.
What pre-care actually means, and why it matters
Pre-care is not a counselling prerequisite or a gatekeeping mechanism presented in warmer language. It is the structured clinical and psychological support that prepares someone for a significant physiological change: what to expect from hormones, how long changes take, what varies between individuals, what to monitor, when to seek help, and how to think through the decisions ahead in a way that is genuinely informed rather than simply bureaucratically compliant.
Every other area of medicine takes this seriously. Someone facing a significant cardiac intervention receives preparation. Someone beginning chemotherapy is walked through the likely course of treatment, the side effects, the markers to watch for, the support available along the way. The clinical standard is not: here is the prescription, good luck.
Trans people are handed precisely that standard. The waiting list is long, the appointment is short, and the preparation is almost nonexistent. By the time someone reaches the point of receiving care, they have often spent years researching independently, building knowledge from peer communities and online forums, because the clinical system never provided what it should have. That peer knowledge is real and often excellent. It is also no substitute for structured pre-care from a clinician who knows their individual picture.
What post-care actually means, and why its absence causes harm
Post-care is the ongoing clinical and psychological support that follows a transition-related intervention. It is not surveillance. It is not a mechanism for reviewing whether the decision was correct. It is the same standard of follow-up that any other significant medical treatment receives: monitoring, adjustment, guidance, and a named point of contact when something unexpected arises.
Hormones change the body over years, not weeks. Testosterone and oestrogen affect cardiovascular risk, bone density, mood, metabolism, and a range of other systems in ways that evolve over time and that vary significantly between individuals. The clinical standard for any long-term hormone therapy is regular monitoring, dose adjustment as needed, and proactive guidance about what to expect at each stage. For trans people, that standard is rarely met.
Surgical post-care is, if anything, worse. Someone who has undergone a major gender-affirming surgical procedure frequently finds that follow-up is sparse, geographically unavailable, or provided by clinicians who lack the specific expertise the recovery requires. The result is that complications go unrecognised, questions go unanswered, and the psychological adjustment that follows any significant surgery is navigated without support.
And then, when outcomes are poorer than they should be, the system looks at those outcomes and draws the wrong conclusion. The failure of post-care becomes evidence, in some hands, against the care itself. That is a profound inversion of clinical accountability.
This is a healthcare design failure, not a trans problem
The fault lies with the system, not with trans people, and that matters for how we fix it.
Trans people are not failing to access support that exists. They are being failed by a system that never built it. The absence of pre-care and post-care in trans healthcare is not an oversight that crept in at the margins. It reflects something deeper: a set of assumptions, embedded across decades of gatekeeping culture, that trans people's role in the system is to prove they deserve the intervention, not to be supported through it.
The assessment model that dominated trans healthcare for so long was never designed around the patient's needs. It was designed around institutional hesitation. And when that model finally gives way, often under pressure from patients who have waited years and from clinicians who have grown frustrated with it, what replaces it is frequently just the intervention with the gatekeeping stripped out. The support that should have been there all along simply never arrives.
The result is a system that manages to combine the worst features of both approaches: the delays and demands of the old gatekeeping model, and the absence of genuine clinical support that a properly resourced patient-centred model would provide.
What good pre-care and post-care would look like
It is worth saying plainly what the alternative is, because the absence of it can make the current situation feel like the only possible one.
Good pre-care means a structured conversation, or series of conversations, before any medical intervention begins. Not a psychiatric assessment of whether someone is trans. A clinical preparation: what this treatment does, how it works in the body, what the timeline of changes looks like, what monitoring is needed, what to watch for, and what questions to bring back. It means someone knowing who to contact if something unexpected happens in the first weeks. It means informed consent that is genuinely informed, not a box ticked on a form.
Good post-care means a follow-up pathway, built in from the start. Not an open-ended promise that the person can contact the service if they have concerns, which in practice means navigating a waiting list all over again. A structured review at intervals that match the clinical reality of what the treatment does over time. A point of contact for questions that arise between appointments. Psychological support available not as an emergency measure but as a routine part of the pathway, because the changes of transition, welcome as they are, are significant, and navigating them with clinical support produces better outcomes than navigating them alone.
None of this is radical. It is the standard that other areas of long-term care already meet. The question is why trans healthcare has been exempt from it for so long, and who has paid the price for that exemption.
The policy case, stated plainly
For those reading this with an eye on commissioning, service design, or clinical governance, the argument reduces to something simple. Structured pre-care and post-care improve outcomes. Better outcomes reduce downstream demand on other services. They reduce emergency presentations, reduce the clinical complexity of managing complications that adequate follow-up would have caught, and reduce the psychological burden that inadequately supported transitions place on mental health services.
The cost of building pre-care and post-care into trans healthcare pathways is real. The cost of not doing so is higher, and it falls almost entirely on the trans people who needed the support and were not given it. That is not a trade-off anyone in health policy should be comfortable defending.
Trans people deserve the same standard of clinical care that any other patient population receives for any other significant, long-term medical treatment. Pre-care and post-care are not additional requirements. They are the baseline. The gap between that baseline and what currently exists is not a feature of trans healthcare. It is the failure of it.
If there is a topic that you would like me to cover, just let Sammy know.
Dr Helen Webberley is a gender specialist, medical educator, and advocate, and the founder of GenderGP. She writes about gender diversity, trans healthcare, and the lives at the centre of both.
Comments